Study to Evaluate the Pharmacokinetic Characteristics and Safety of IN-C004 in Healthy Volunteers

An Open-label, Randomized, Single-dose, Crossover Study to Evaluate the Pharmacokinetic Characteristics and Safety of IN-C004 in Healthy Volunteers

To evaluate the pharmacokinetic characteristics and safety of IN-C004 in healthy volunteers

An Open-label, Randomized, Single-dose, Crossover Study

Inclusion Criteria:

• Body mass index (BMI) ≥19.0 kg/m2 and ≤27.0 kg/m2 with a body weight ≥ 45 kg at screening.

Exclusion Criteria:

• History or evidence of clinically significant disease
• History of drug/alcohol abuse
• Participated in other studies and received investigational products within 6 months prior to the first study dose.
• AST(GOT) or ALT(GPT) > 2 X upper limit of normal at screening
• Not able to use a medically acceptable contraceptive method throughout the study.